![]() |
市场调查报告书
商品编码
1642794
军团菌检测市场报告(按应用(水检测、IVD 检测)、最终用户(诊断实验室、医院和诊所等)和地区)2025-2033 年Legionella Testing Market Report by Application (Water Testing, IVD Testing), End User (Diagnostic Laboratories, Hospital and Clinics, and Others), and Region 2025-2033 |
2024年,全球军团菌检测市场规模达3.665IMARC Group美元。越来越多的糖尿病、肾臟病、人类免疫缺陷病毒(HIV)、癌症或其他慢性疾病患者面临住院风险,刺激了市场成长。
军团菌是一种影响下呼吸道的感染,可导致严重肺炎、庞蒂亚克热和类似流感症状的疾病。其测试有助于识别血液、尿液和痰中是否有细菌或抗原。目前,诊断退伍军人菌症的检测方法有多种,包括尿液抗原、配对血清学、聚合酶链反应(PCR)、直接萤光抗体(DFA)染色、下呼吸道分泌物培养等。根据检测结果,通常对患者给予大环内酯类、喹诺酮类、四环素、强力霉素、米诺环素、甲氧芐啶等抗生素治疗。
50 岁以上的成年人更容易感染军团菌。因此,全球老年人口的增加是正面影响市场的主要因素之一。此外,越来越多的吸烟者和患有癌症、糖尿病、肾臟病、人类免疫缺陷病毒(HIV)或其他慢性疾病的人面临感染和住院的风险。由于军团菌的死亡率很高,对其有效的诊断测试和治疗的需求不断增加。除此之外,引起军团菌的细菌主要存在于不同的自然和人工水生环境中,例如冷却水塔、呼吸治疗设备、喷泉、喷雾装置、水疗池以及饭店、家庭和工厂的供水系统。因此,许多国家的卫生机构正在製定有效的水安全计画(WSP),以尽量减少军团菌在水中的扩散。这反过来又增加了在工作场所进行军团菌测试以遵守立法的需求。此外,最近针对成人社区型肺炎患者的诊断和治疗策略的临床试验也促进了市场的成长。
水质测试
微生物培养
DFA染色
聚合酶炼式反应
其他的
体外诊断测试
血液培养
尿液抗原测试
DFA染色
聚合酶炼式反应
其他的
诊断实验室
医院和诊所
其他的
欧洲
义大利
德国
法国
西班牙
英国
俄罗斯
其他的
北美洲
美国
加拿大
亚太地区
中国
日本
澳洲
韩国
印尼
新加坡
其他的
拉丁美洲
巴西
墨西哥
其他的
中东和非洲
该行业的竞争格局也得到了检验,一些主要参与者包括 Abbott Laboratories、Becton、Dickinson and Company、BioMerieux SA、Bio-Rad Laboratories Inc、Eiken Chemical Co. Ltd、Quidel Corporation、Takara Bio Inc. 和赛默飞世尔科技公司
The global legionella testing market size reached USD 366.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 658.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.66% during 2025-2033. The increasing number of individuals who have diabetes, kidney disease, human immunodeficiency virus (HIV), cancer, or other chronic illnesses, are at risk of hospitalization, which is stimulating the market growth.
Legionella is an infection affecting the lower respiratory tract, which can lead to severe pneumonia, Pontiac fever, and illness with flu-like symptoms. Its testing helps to identify the existence of bacteria or antigens in blood, urine, and sputum. Presently, various testing methods are available to diagnose Legionella disease, including urinary antigen, paired serology, Polymerase Chain Reaction (PCR), Direct Fluorescent Antibody (DFA) stain, and culture of lower respiratory secretions. As per the testing results, macrolides, quinolones, tetracycline, doxycycline, minocycline, trimethoprim and other antibiotic treatments are usually administered to patients.
Adults over the age of 50 years are more likely to develop Legionella. Consequently, the increasing geriatric population worldwide represents one of the major factors influencing the market positively. Moreover, the rising number of individuals who smoke and have cancer, diabetes, kidney disease, human immunodeficiency virus (HIV), or other chronic illnesses are at the risk of infection and hospitalization. Since the mortality rate of Legionella is high, there is an increase in the demand for its effective diagnostic tests and treatments. Besides this, Legionella-causing bacteria are majorly found in different natural and artificial aquatic environments, such as cooling towers, respiratory therapy equipment, fountains, misting devices, spa pools, and water systems in hotels, homes, and factories. As a result, health agencies of numerous countries are developing an effective water safety plan (WSP) to minimize the proliferation of Legionella in the water. This, in turn, is escalating the demand for Legionella testing in workplace buildings to comply with the legislation. Furthermore, recent clinical trials on diagnostic and treatment strategies for adult patients with community-acquired pneumonia are contributing to the growth of the market.
Water Testing
Microbial Culture
DFA Stain
PCR
Others
IVD Testing
Blood Culture
Urine Antigen Test
DFA Stain
PCR
Others
Diagnostic Laboratories
Hospital and Clinics
Others
Europe
Italy
Germany
France
Spain
United Kingdom
Russia
Others
North America
United States
Canada
Asia Pacific
China
Japan
Australia
South Korea
Indonesia
Singapore
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc, Eiken Chemical Co. Ltd, Quidel Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc.